Insulet (PODD) Equity Average (2016 - 2025)
Historic Equity Average for Insulet (PODD) over the last 15 years, with Q3 2025 value amounting to $1.4 billion.
- Insulet's Equity Average rose 3452.09% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 3452.09%. This contributed to the annual value of $972.2 million for FY2024, which is 6080.56% up from last year.
- Per Insulet's latest filing, its Equity Average stood at $1.4 billion for Q3 2025, which was up 3452.09% from $1.4 billion recorded in Q2 2025.
- Over the past 5 years, Insulet's Equity Average peaked at $1.4 billion during Q3 2025, and registered a low of $425.2 million during Q3 2022.
- Its 5-year average for Equity Average is $746.1 million, with a median of $580.7 million in 2023.
- Within the past 5 years, the most significant YoY rise in Insulet's Equity Average was 78131.95% (2021), while the steepest drop was 1737.89% (2021).
- Quarter analysis of 5 years shows Insulet's Equity Average stood at $527.1 million in 2021, then decreased by 14.21% to $452.2 million in 2022, then skyrocketed by 48.19% to $670.1 million in 2023, then surged by 73.82% to $1.2 billion in 2024, then grew by 22.21% to $1.4 billion in 2025.
- Its Equity Average was $1.4 billion in Q3 2025, compared to $1.4 billion in Q2 2025 and $1.3 billion in Q1 2025.